These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20624511

  • 1. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME, Baker B, Frasure-Smith N, Swenson JR, Koszycki D, Butler G, van Zyl LT, Lespérance F.
    J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 4. Placebo response and antidepressant response.
    Alexopoulos GS, Kanellopoulos D, Murphy C, Gunning-Dixon F, Katz R, Heo M.
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.
    J Clin Psychiatry; 2010 Sep; 71(9):1125-30. PubMed ID: 20441723
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ.
    Biol Psychiatry; 2005 Dec 01; 58(11):865-70. PubMed ID: 15993860
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
    von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hultén A.
    J Clin Psychopharmacol; 2006 Jun 01; 26(3):311-5. PubMed ID: 16702897
    [Abstract] [Full Text] [Related]

  • 8. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    J Psychiatr Res; 2010 Apr 01; 44(6):339-46. PubMed ID: 19909979
    [Abstract] [Full Text] [Related]

  • 9. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD, Shults J, Rutherford N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):100-6. PubMed ID: 17804135
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
    Shoval G, Nahshoni E, Gothelf D, Manor I, Golobchik P, Zemishlany Z, Weizman A, Zalsman G.
    Clin Neuropharmacol; 2011 Jan 01; 34(5):182-5. PubMed ID: 21926484
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Fantino B, Moore N, Verdoux H, Auray JP.
    Int Clin Psychopharmacol; 2007 Mar 01; 22(2):107-15. PubMed ID: 17293711
    [Abstract] [Full Text] [Related]

  • 12. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 01; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul 01; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 01; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 15. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
    Rosenberg C, Lauritzen L, Brix J, Jørgensen JB, Kofod P, Bayer LB.
    Psychopharmacol Bull; 2007 Dec 01; 40(1):63-73. PubMed ID: 17285097
    [Abstract] [Full Text] [Related]

  • 16. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec 01; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 17. The effect of escitalopram on sleep problems in depressed patients.
    Lader M, Andersen HF, Baekdal T.
    Hum Psychopharmacol; 2005 Jul 01; 20(5):349-54. PubMed ID: 15912558
    [Abstract] [Full Text] [Related]

  • 18. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007 Jul 01; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 19. Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.
    Khajavi D, Farokhnia M, Modabbernia A, Ashrafi M, Abbasi SH, Tabrizi M, Akhondzadeh S.
    J Clin Psychiatry; 2012 Nov 01; 73(11):1428-33. PubMed ID: 23146150
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM, Azorin JM, Despiegel N, Verpillat P.
    Int J Clin Pract; 2005 Mar 01; 59(3):268-75. PubMed ID: 15857321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.